Cell Based Assays Market: By Product Type By Application, By End-User & By Geography - Forecast 2016-2021

  • ID: 3973978
  • Report
  • 162 pages
  • IndustryARC
1 of 3
Cell based assay is defined as a technique for analysing the living cell on the basis of different parameters. This technology is basically used to measure virtually of cellular or biochemical functions. Functional cells are used as diagnostic tools in research for new drugs in the cell based assays technique. Cell based assays helps in measuring cell proliferations, motility, toxicity, production of a measurable product and morphology in diagnostics and drug discovery. This technique is used by pharmaceutical companies, academic research institutes, biotechnology companies, government institutions, contract research organizations and others. Cell based assays also facilitate research in the area of stem cells, cancer, immunology and others.

This report identifies the cell based assays market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to cell based assays market.

Globally North America dominated the market for cell based assays in 2015 due to higher increasing R&D activities and penetration of the cell based assays in end-use industry. North America is expected to continue its domination and was followed by Europe and Asia-Pacific as the second and third largest markets respectively in 2015. However Asia-Pacific is expected to be the fastest growing market due to technological advancement and increasing R&D activities in life science and drug activities.

This report on global cell based assays also covers different type of cell based assays available, applications of cell based assays, end-user industry and market size in various geographical regions.

On the basis of type of cell based assays this report classifies as follows covering all major types of cell based assays available in the market: Consumables (Microplates, Cell Lines, Reagents & Assay Kits and Others), Instruments, Software and Service

This report cell based assays market is also segmented on the basis of major end-use applications of cell based assays, some of the major applications of cell based assays are: Drug Discovery, Basic Research, Predictive Toxicology and Other Applications
This report cell based assays market is also segmented on the basis of major end-use industry of cell based assays, some of the major end-use industry of cell based assays are: Pharmaceutical & Healthcare, Government Institutions and Others
This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for cell based assays in each of the region.

This report identifies all the major companies operating in the global cell based assays market. Some of the major companies’ profiles in detail are as follows:
Becton, Dickinson and Company
General Electric Company
Thermo Fisher Scientific Inc
Cell Signaling Technology, Inc.
Danaher Corporation
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Cell Based Assays – Market Overview

2. Executive Summary

3. Cell Based Assays Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End User Profiling
3.2.3. Top 5 Financials Analysis

4. Cell Based Assays – Market Forces
4.1. Drivers
4.1.1. Increasing government initiatives& funding to support and promote R&D
4.2. Restraints
4.2.1. High Infrastructure Cost
4.3. Opportunities
4.4. Challenges
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition

5. Cell Based Assays Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors

6. Global Cell Based Assays Market, By Product Type
6.1. Consumables
6.1.1. Microplates
6.1.2. Cell Lines
6.1.3. Reagents & Assay Kits
6.1.4. Others
6.2. Instruments
6.3. Software
6.4. Service

7. Global Cell Based Assays Market, By Application
7.1. Drug Discovery
7.2. Basic Research
7.3. Predictive Toxicology
7.4. Other Applications

8. Global Cell Based Assays Market, By End-Use Industry
8.1. Pharmaceutical & Healthcare
8.2. Government Institutions
8.3. Others

9. Global Cell Based Assays Market, By Geography
9.1. Europe
9.1.1. Germany
9.1.2. France
9.1.3. Italy
9.1.4. Spain
9.1.5. Russia
9.1.6. U.K.
9.1.7. Rest of Europe
9.2. Asia Pacific
9.2.1. China
9.2.2. India
9.2.3. Japan
9.2.4. South Korea
9.2.5. Rest of Asia-Pacific
9.3. North America
9.3.1. U.S.
9.3.2. Canada
9.3.3. Mexico
9.4. Rest of the World (RoW)
9.4.1. Brazil
9.4.2. Rest of RoW

10. Cell Based Assays – Market Entropy
10.1. Expansion
10.2. Technological Developments
10.3. Merger & Acquisitions, and Joint Ventures
10.4. Supply- Contract

11. Company Profiles
11.1. Becton, Dickinson and Company
11.1.1. Introduction
11.1.2. Financials
11.1.3. Key Insights
11.1.4. Key Strategy
11.1.5. Product Portfolio
11.1.6. SWOT Analysis
11.2. General Electric Company
11.2.1. Introduction
11.2.2. Financials
11.2.3. Key Insights
11.2.4. Key Strategy
11.2.5. Product Portfolio
11.2.6. SWOT Analysis
11.3. Thermo Fisher Scientific Inc
11.3.1. Introduction
11.3.2. Financials
11.3.3. Key Insights
11.3.4. Key Strategy
11.3.5. Product Portfolio
11.3.6. SWOT Analysis
11.4. Cell Signaling Technology, Inc.
11.4.1. Introduction
11.4.2. Financials
11.4.3. Key Insights
11.4.4. Key Strategy
11.4.5. Product Portfolio
11.4.6. SWOT Analysis
11.5. Danaher Corporation
11.5.1. Introduction
11.5.2. Financials
11.5.3. Key Insights
11.5.4. Key Strategy
11.5.5. Product Portfolio
11.5.6. SWOT Analysis
11.6. Cisbio Bioassays
11.6.1. Introduction
11.6.2. Financials
11.6.3. Key Insights
11.6.4. Key Strategy
11.6.5. Product Portfolio
11.6.6. SWOT Analysis
11.7. Danaher Corporation
11.7.1. Introduction
11.7.2. Financials
11.7.3. Key Insights
11.7.4. Key Strategy
11.7.5. Product Portfolio
11.7.6. SWOT Analysis
11.8. Promega Corporation
11.8.1. Introduction
11.8.2. Financials
11.8.3. Key Insights
11.8.4. Key Strategy
11.8.5. Product Portfolio
11.8.6. SWOT Analysis
11.9. Merck & Co., Inc.
11.9.1. Introduction
11.9.2. Financials
11.9.3. Key Insights
11.9.4. Key Strategy
11.9.5. Product Portfolio
11.9.6. SWOT Analysis
11.10. Perkinelmer, Inc.
11.10.1. Introduction
11.10.2. Financials
11.10.3. Key Insights
11.10.4. Key Strategy
11.10.5. Product Portfolio
11.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Expert Insights
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown